Literature DB >> 11804319

Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.

Chick Weisse1, Frances S Shofer, Karin Sorenmo.   

Abstract

A retrospective study was performed on 31 dogs with completely excised, grade II, cutaneous mast cell tumors in order to determine recurrence rates and sites. Distant tumor recurrence developed in 22% of dogs, and local tumor recurrence developed in 11% of dogs; however, the vast majority of these animals were incompletely staged initially. Complete surgical excision of grade II mast cell tumors was associated with effective local control in 89% of these dogs. Therefore, adjuvant radiation therapy might not be indicated in the majority of dogs with complete surgical excision.

Entities:  

Mesh:

Year:  2002        PMID: 11804319     DOI: 10.5326/0380071

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  11 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  The effect of prednisone on histologic and gross characteristics in canine mast cell tumors.

Authors:  Ken J Linde; Stephen L Stockdale; Michael B Mison; James A Perry
Journal:  Can Vet J       Date:  2021-01       Impact factor: 1.008

3.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

4.  A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.

Authors:  Suzanne Bartholf DeWitt; William C Eward; Cindy A Eward; Alexander L Lazarides; Melodi Javid Whitley; Jorge M Ferrer; Brian E Brigman; David G Kirsch; John Berg
Journal:  Vet Surg       Date:  2016-06-09       Impact factor: 1.495

5.  Evaluation of information presented within mast cell tumour histopathology reports in the United States: 2012-2015.

Authors:  Jennifer K Reagan; Laura E Selmic; Caroline Fallon; Elizabeth A Driskell; Laura D Garrett
Journal:  Vet Med Sci       Date:  2018-06-07

6.  Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.

Authors:  Jaime A Olsen; Maurine Thomson; Kathleen O'Connell; Ken Wyatt
Journal:  Vet Med Sci       Date:  2018-05-24

Review 7.  Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.

Authors:  Andrigo Barboza de Nardi; Rodrigo Dos Santos Horta; Carlos Eduardo Fonseca-Alves; Felipe Noleto de Paiva; Laís Calazans Menescal Linhares; Bruna Fernanda Firmo; Felipe Augusto Ruiz Sueiro; Krishna Duro de Oliveira; Silvia Vanessa Lourenço; Ricardo De Francisco Strefezzi; Carlos Henrique Maciel Brunner; Marcelo Monte Mor Rangel; Paulo Cesar Jark; Jorge Luiz Costa Castro; Rodrigo Ubukata; Karen Batschinski; Renata Afonso Sobral; Natália Oyafuso da Cruz; Adriana Tomoko Nishiya; Simone Crestoni Fernandes; Simone Carvalho Dos Santos Cunha; Daniel Guimarães Gerardi; Guilherme Sellera Godoy Challoub; Luiz Roberto Biondi; Renee Laufer-Amorim; Paulo Ricardo de Oliveira Paes; Gleidice Eunice Lavalle; Rafael Ricardo Huppes; Fabrizio Grandi; Carmen Helena de Carvalho Vasconcellos; Denner Santos Dos Anjos; Ângela Cristina Malheiros Luzo; Julia Maria Matera; Miluse Vozdova; Maria Lucia Zaidan Dagli
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

8.  Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.

Authors:  Joshua D Webster; Vilma Yuzbasiyan-Gurkan; Douglas H Thamm; Elizabeth Hamilton; Matti Kiupel
Journal:  BMC Vet Res       Date:  2008-08-13       Impact factor: 2.741

9.  Cutaneous mast cell tumor (Mastocytoma): cyto- histopathological and haematological investigations.

Authors:  Ehsan Hosseini; Behnam Pedram; Ali Mohammad Bahrami; Mohammad Hossein Jaberi Moghaddam; Javad Javanbakht; Fatemeh Emami Ghomi; Najme Jaberi Moghaddam; Mobin Koohestani; Radmehr Shafiee
Journal:  Diagn Pathol       Date:  2014-01-20       Impact factor: 2.644

10.  Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate.

Authors:  Pamela D Jones; Justine E Campbell; Graham Brown; Chad M Johannes; Paul Reddell
Journal:  J Vet Intern Med       Date:  2020-12-22       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.